Perspectives
25 Medicare contracts earn quality bonuses
CMS releases its latest Star Ratings: A look at Prime-supported Medicare contracts that earned quality bonus payments from getting a 4+ Star Rating
November 11, 2022“These results highlight how Prime works to make health care more affordable for members,” says Kip Haffner, vice president, government programs. “The payments are worth hundreds of millions of dollars to our health plan clients to help them better serve their members.”
These results mean that 73% of our Medicare Advantage Prescription Drug (MAPD) members are covered by a plan with an overall rating of 4 or more Stars.
Stars and total drug management
Star ratings have 40 measures that combine for one rating:
- Part C measures mostly the health plan and medical benefit
- Part D measures the drug benefit
As a pharmacy benefit manager, Prime influences many of the Part D measures reflecting:
- Operations
- Customer experience
- Medication adherence
Continuous improvement
CMS evaluates performance data each year and may adjust the measures for all metrics. This makes it more challenging to earn higher Star ratings.
“We have a strong foundation,” explains Kip Haffner. “Our adherence programs are clinically sound and validated by research. Our operations are becoming industry-leading. We build on these strengths every year. CMS can raise the bar, and here at Prime, we’ll keep innovating,” he said.
Prime continues to innovate with our Blue Plan clients providing products and services that deliver improved quality to members.
Take a look at some of the award-winning research behind these products. SmartAdherence™ Missed Refill Program, lower cost share generics and Quality-Based Network. And you’ll see how Prime is helping to make health care work better.
Related news
Perspectives
May 7, 2024
Prime/MRx helps clients and members navigate drug shortages
Constant communication across the supply chain limits disruption when a drug is unavailable
Perspectives
May 1, 2024
Prime Therapeutics releases new clinical insights report, “Weight management: A holistic journey”
Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss
Perspectives
April 30, 2024
AMCP 2024: Behind the GLP-1 Spotlight Session with Ben Urick
Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting